CN Stock MarketDetailed Quotes

002020 Zhejiang Jingxin Pharmaceutical

Watchlist
  • 10.78
  • -0.05-0.46%
Market Closed Aug 14 15:00 CST
9.28BMarket Cap13.16P/E (TTM)

Zhejiang Jingxin Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
Total operating revenue
11.02%2.15B
10.44%1.06B
5.79%4B
4.48%2.93B
3.41%1.94B
10.32%960.43M
9.04%3.78B
9.29%2.8B
8.46%1.87B
1.52%870.57M
Operating revenue
11.02%2.15B
10.44%1.06B
5.79%4B
4.48%2.93B
3.41%1.94B
10.32%960.43M
9.04%3.78B
9.29%2.8B
8.46%1.87B
1.52%870.57M
Other operating revenue
-12.59%36.23M
----
25.61%78.89M
----
54.02%41.45M
----
-3.47%62.81M
----
-15.42%26.91M
----
Total operating cost
8.37%1.74B
8.14%870.67M
9.15%3.37B
5.77%2.43B
3.37%1.6B
11.04%805.17M
8.56%3.08B
8.26%2.3B
6.79%1.55B
-1.92%725.13M
Operating cost
8.63%1.04B
6.23%510.34M
11.91%1.98B
11.69%1.43B
12.34%958.38M
22.29%480.39M
14.41%1.77B
12.64%1.28B
9.92%853.08M
2.55%392.82M
Operating tax surcharges
13.44%22.62M
4.15%10.14M
22.83%46.75M
3.97%30.14M
4.31%19.94M
5.37%9.74M
28.52%38.06M
18.39%28.99M
20.91%19.11M
8.67%9.24M
Operating expense
-3.63%383.81M
3.67%207.9M
-1.02%783.53M
-10.79%605.89M
-12.86%398.28M
-8.09%200.54M
0.33%791.58M
7.17%679.2M
5.31%457.04M
-6.41%218.2M
Administration expense
47.57%127.71M
30.53%52.08M
9.70%213.17M
16.91%142.24M
9.55%86.55M
0.37%39.9M
6.64%194.33M
-3.12%121.66M
-1.96%79.01M
-7.46%39.76M
Financial expense
-12.24%-36.66M
-30.96%-8.18M
25.57%-53.83M
35.60%-38.24M
-12.65%-32.66M
55.76%-6.24M
-92.44%-72.32M
-125.93%-59.38M
-119.82%-28.99M
-109.53%-14.11M
-Interest expense (Financial expense)
35.79%6.09M
65.88%3.74M
21.61%7.31M
16.89%6.24M
--4.49M
--2.25M
20.96%6.01M
--5.34M
----
----
-Interest Income (Financial expense)
-29.84%-41.61M
12.84%-11.74M
8.18%-60.27M
16.08%-41.94M
---32.05M
---13.47M
-36.37%-65.64M
---49.97M
----
----
Research and development
15.14%197.02M
21.70%98.38M
9.23%400.93M
5.30%259.46M
0.57%171.12M
2.04%80.84M
9.68%367.06M
8.12%246.4M
7.94%170.16M
1.01%79.22M
Credit Impairment Loss
-413.96%-12.62M
-124.45%-3.15M
-368.89%-5.14M
-71.55%599.4K
44.02%-2.45M
-14.10%-1.41M
110.92%1.91M
115.91%2.11M
57.75%-4.39M
41.27%-1.23M
Asset Impairment Loss
-55.01%1.41M
-142.75%-1.93M
-1.18%-21.15M
171.38%1.48M
552.20%3.13M
1,921.06%4.53M
-103.46%-20.9M
1,662.63%545.72K
251.48%480.22K
62,253.95%223.93K
Other net revenue
108.54%61.88M
-38.57%12.06M
33.50%82.26M
25.56%43.01M
23.93%29.67M
101.84%19.64M
-15.61%61.62M
-30.87%34.25M
-33.44%23.95M
-69.90%9.73M
Fair value change income
-14.83%853.42K
-70.38%176.71K
53.52%36.77M
35.50%1.34M
95.72%1M
3,496.10%596.6K
231.16%23.95M
-76.78%987.62K
-85.04%511.96K
-99.13%16.59K
Invest income
-102.93%-132.06K
-48.62%1.79M
-66.83%6.44M
19,134.44%6.65M
-56.56%4.5M
-32.29%3.49M
-59.68%19.42M
-99.84%34.6K
-22.06%10.36M
-71.52%5.15M
-Including: Investment income associates
----
----
-45.08%-6.04M
----
----
----
2.05%-4.16M
----
----
----
Asset deal income
-94.46%239.4K
101.86%1.67K
1,018.79%6.86M
1,425.87%4.63M
862.24%4.33M
-119.76%-90.02K
227.37%613.14K
143.12%303.5K
288.62%449.49K
294.40%455.46K
Other revenue
276.28%72.13M
21.25%15.18M
59.65%58.47M
-6.51%28.3M
16.00%19.17M
145.02%12.52M
-20.16%36.62M
-19.91%30.27M
-45.26%16.53M
-65.13%5.11M
Operating profit
30.59%476.17M
15.53%202.05M
-5.62%714.06M
0.29%535.49M
4.98%364.62M
12.71%174.9M
8.39%756.62M
9.72%533.94M
11.39%347.31M
3.11%155.17M
Add:Non operating Income
195.25%4.71M
-61.34%177.64K
81.12%2.47M
86.77%1.9M
425.36%1.59M
416.74%459.54K
-24.86%1.36M
-45.11%1.02M
-77.12%303.49K
-91.42%88.93K
Less:Non operating expense
-38.35%756.4K
-76.10%114.34K
10.76%8.49M
-40.48%1.3M
-29.96%1.23M
198.83%478.43K
2,203.09%7.66M
746.30%2.18M
949.37%1.75M
186.03%160.1K
Total profit
31.55%480.12M
15.58%202.12M
-5.63%708.04M
0.62%536.09M
5.53%364.99M
12.75%174.88M
7.26%750.32M
9.12%532.78M
10.52%345.86M
2.39%155.1M
Less:Income tax cost
59.55%74.25M
24.98%28.91M
2.58%84.62M
4.94%60.14M
0.04%46.54M
34.21%23.13M
1.13%82.49M
19.21%57.31M
40.51%46.52M
-2.93%17.23M
Net profit
27.45%405.87M
14.14%173.21M
-6.65%623.42M
0.10%475.95M
6.38%318.45M
10.07%151.75M
8.07%667.82M
8.02%475.47M
6.97%299.34M
3.10%137.87M
Net profit from continuing operation
27.45%405.87M
14.14%173.21M
-6.66%623.61M
0.10%475.95M
6.38%318.45M
10.07%151.75M
8.11%668.11M
8.02%475.47M
6.97%299.34M
3.10%137.87M
Net income from discontinuing operating
----
----
34.38%-190.89K
----
----
----
-1,175.40%-290.92K
----
----
----
Less:Minority Profit
48.54%3.75M
264.13%2M
-18.84%4.52M
-10.47%3.33M
10.28%2.52M
-8.90%550.43K
2.71%5.57M
227.02%3.72M
2,222.04%2.29M
312.17%604.24K
Net profit of parent company owners
27.28%402.12M
13.23%171.21M
-6.55%618.9M
0.18%472.62M
6.35%315.92M
10.15%151.2M
8.12%662.25M
7.45%471.75M
6.19%297.05M
2.43%137.26M
Earning per share
Basic earning per share
27.03%0.47
11.11%0.2
-6.49%0.72
0.00%0.55
5.71%0.37
12.50%0.18
2.67%0.77
0.00%0.55
0.00%0.35
-5.88%0.16
Diluted earning per share
27.03%0.47
11.11%0.2
-6.49%0.72
0.00%0.55
5.71%0.37
12.50%0.18
2.67%0.77
0.00%0.55
0.00%0.35
-5.88%0.16
Other composite income
-32.94%385.58K
87.81%284.4K
-125.77%-333.76K
0.67%680.9K
57.02%574.99K
-31.92%151.43K
12,175.85%1.3M
1,542.70%676.4K
1,159.46%366.18K
56.06%222.43K
Other composite income of parent company owners
-32.46%381.59K
101.47%274.28K
-125.72%-333.9K
1.59%667.61K
60.16%565.02K
-35.21%136.14K
8,775.33%1.3M
1,713.03%657.13K
1,281.77%352.79K
55.81%210.13K
Other composite income of minority owners
-59.94%3.99K
-33.84%10.12K
104.49%139.42
-31.00%13.3K
-25.62%9.96K
24.26%15.29K
-173.28%-3.11K
290.78%19.27K
278.04%13.39K
60.57%12.31K
Total composite income
27.34%406.26M
14.22%173.5M
-6.88%623.08M
0.10%476.63M
6.45%319.02M
10.00%151.9M
8.28%669.12M
8.16%476.15M
7.09%299.7M
3.16%138.09M
Total composite income of parent company owners
27.18%402.5M
13.31%171.48M
-6.78%618.56M
0.19%473.29M
6.42%316.49M
10.08%151.33M
8.33%663.55M
7.59%472.41M
6.30%297.4M
2.48%137.47M
Total composite income of minority owners
48.11%3.75M
256.08%2.01M
-18.79%4.52M
-10.58%3.34M
10.07%2.53M
-8.24%565.73K
2.57%5.57M
227.29%3.74M
2,154.56%2.3M
322.48%616.55K
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Auditor
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022
Total operating revenue 11.02%2.15B10.44%1.06B5.79%4B4.48%2.93B3.41%1.94B10.32%960.43M9.04%3.78B9.29%2.8B8.46%1.87B1.52%870.57M
Operating revenue 11.02%2.15B10.44%1.06B5.79%4B4.48%2.93B3.41%1.94B10.32%960.43M9.04%3.78B9.29%2.8B8.46%1.87B1.52%870.57M
Other operating revenue -12.59%36.23M----25.61%78.89M----54.02%41.45M-----3.47%62.81M-----15.42%26.91M----
Total operating cost 8.37%1.74B8.14%870.67M9.15%3.37B5.77%2.43B3.37%1.6B11.04%805.17M8.56%3.08B8.26%2.3B6.79%1.55B-1.92%725.13M
Operating cost 8.63%1.04B6.23%510.34M11.91%1.98B11.69%1.43B12.34%958.38M22.29%480.39M14.41%1.77B12.64%1.28B9.92%853.08M2.55%392.82M
Operating tax surcharges 13.44%22.62M4.15%10.14M22.83%46.75M3.97%30.14M4.31%19.94M5.37%9.74M28.52%38.06M18.39%28.99M20.91%19.11M8.67%9.24M
Operating expense -3.63%383.81M3.67%207.9M-1.02%783.53M-10.79%605.89M-12.86%398.28M-8.09%200.54M0.33%791.58M7.17%679.2M5.31%457.04M-6.41%218.2M
Administration expense 47.57%127.71M30.53%52.08M9.70%213.17M16.91%142.24M9.55%86.55M0.37%39.9M6.64%194.33M-3.12%121.66M-1.96%79.01M-7.46%39.76M
Financial expense -12.24%-36.66M-30.96%-8.18M25.57%-53.83M35.60%-38.24M-12.65%-32.66M55.76%-6.24M-92.44%-72.32M-125.93%-59.38M-119.82%-28.99M-109.53%-14.11M
-Interest expense (Financial expense) 35.79%6.09M65.88%3.74M21.61%7.31M16.89%6.24M--4.49M--2.25M20.96%6.01M--5.34M--------
-Interest Income (Financial expense) -29.84%-41.61M12.84%-11.74M8.18%-60.27M16.08%-41.94M---32.05M---13.47M-36.37%-65.64M---49.97M--------
Research and development 15.14%197.02M21.70%98.38M9.23%400.93M5.30%259.46M0.57%171.12M2.04%80.84M9.68%367.06M8.12%246.4M7.94%170.16M1.01%79.22M
Credit Impairment Loss -413.96%-12.62M-124.45%-3.15M-368.89%-5.14M-71.55%599.4K44.02%-2.45M-14.10%-1.41M110.92%1.91M115.91%2.11M57.75%-4.39M41.27%-1.23M
Asset Impairment Loss -55.01%1.41M-142.75%-1.93M-1.18%-21.15M171.38%1.48M552.20%3.13M1,921.06%4.53M-103.46%-20.9M1,662.63%545.72K251.48%480.22K62,253.95%223.93K
Other net revenue 108.54%61.88M-38.57%12.06M33.50%82.26M25.56%43.01M23.93%29.67M101.84%19.64M-15.61%61.62M-30.87%34.25M-33.44%23.95M-69.90%9.73M
Fair value change income -14.83%853.42K-70.38%176.71K53.52%36.77M35.50%1.34M95.72%1M3,496.10%596.6K231.16%23.95M-76.78%987.62K-85.04%511.96K-99.13%16.59K
Invest income -102.93%-132.06K-48.62%1.79M-66.83%6.44M19,134.44%6.65M-56.56%4.5M-32.29%3.49M-59.68%19.42M-99.84%34.6K-22.06%10.36M-71.52%5.15M
-Including: Investment income associates ---------45.08%-6.04M------------2.05%-4.16M------------
Asset deal income -94.46%239.4K101.86%1.67K1,018.79%6.86M1,425.87%4.63M862.24%4.33M-119.76%-90.02K227.37%613.14K143.12%303.5K288.62%449.49K294.40%455.46K
Other revenue 276.28%72.13M21.25%15.18M59.65%58.47M-6.51%28.3M16.00%19.17M145.02%12.52M-20.16%36.62M-19.91%30.27M-45.26%16.53M-65.13%5.11M
Operating profit 30.59%476.17M15.53%202.05M-5.62%714.06M0.29%535.49M4.98%364.62M12.71%174.9M8.39%756.62M9.72%533.94M11.39%347.31M3.11%155.17M
Add:Non operating Income 195.25%4.71M-61.34%177.64K81.12%2.47M86.77%1.9M425.36%1.59M416.74%459.54K-24.86%1.36M-45.11%1.02M-77.12%303.49K-91.42%88.93K
Less:Non operating expense -38.35%756.4K-76.10%114.34K10.76%8.49M-40.48%1.3M-29.96%1.23M198.83%478.43K2,203.09%7.66M746.30%2.18M949.37%1.75M186.03%160.1K
Total profit 31.55%480.12M15.58%202.12M-5.63%708.04M0.62%536.09M5.53%364.99M12.75%174.88M7.26%750.32M9.12%532.78M10.52%345.86M2.39%155.1M
Less:Income tax cost 59.55%74.25M24.98%28.91M2.58%84.62M4.94%60.14M0.04%46.54M34.21%23.13M1.13%82.49M19.21%57.31M40.51%46.52M-2.93%17.23M
Net profit 27.45%405.87M14.14%173.21M-6.65%623.42M0.10%475.95M6.38%318.45M10.07%151.75M8.07%667.82M8.02%475.47M6.97%299.34M3.10%137.87M
Net profit from continuing operation 27.45%405.87M14.14%173.21M-6.66%623.61M0.10%475.95M6.38%318.45M10.07%151.75M8.11%668.11M8.02%475.47M6.97%299.34M3.10%137.87M
Net income from discontinuing operating --------34.38%-190.89K-------------1,175.40%-290.92K------------
Less:Minority Profit 48.54%3.75M264.13%2M-18.84%4.52M-10.47%3.33M10.28%2.52M-8.90%550.43K2.71%5.57M227.02%3.72M2,222.04%2.29M312.17%604.24K
Net profit of parent company owners 27.28%402.12M13.23%171.21M-6.55%618.9M0.18%472.62M6.35%315.92M10.15%151.2M8.12%662.25M7.45%471.75M6.19%297.05M2.43%137.26M
Earning per share
Basic earning per share 27.03%0.4711.11%0.2-6.49%0.720.00%0.555.71%0.3712.50%0.182.67%0.770.00%0.550.00%0.35-5.88%0.16
Diluted earning per share 27.03%0.4711.11%0.2-6.49%0.720.00%0.555.71%0.3712.50%0.182.67%0.770.00%0.550.00%0.35-5.88%0.16
Other composite income -32.94%385.58K87.81%284.4K-125.77%-333.76K0.67%680.9K57.02%574.99K-31.92%151.43K12,175.85%1.3M1,542.70%676.4K1,159.46%366.18K56.06%222.43K
Other composite income of parent company owners -32.46%381.59K101.47%274.28K-125.72%-333.9K1.59%667.61K60.16%565.02K-35.21%136.14K8,775.33%1.3M1,713.03%657.13K1,281.77%352.79K55.81%210.13K
Other composite income of minority owners -59.94%3.99K-33.84%10.12K104.49%139.42-31.00%13.3K-25.62%9.96K24.26%15.29K-173.28%-3.11K290.78%19.27K278.04%13.39K60.57%12.31K
Total composite income 27.34%406.26M14.22%173.5M-6.88%623.08M0.10%476.63M6.45%319.02M10.00%151.9M8.28%669.12M8.16%476.15M7.09%299.7M3.16%138.09M
Total composite income of parent company owners 27.18%402.5M13.31%171.48M-6.78%618.56M0.19%473.29M6.42%316.49M10.08%151.33M8.33%663.55M7.59%472.41M6.30%297.4M2.48%137.47M
Total composite income of minority owners 48.11%3.75M256.08%2.01M-18.79%4.52M-10.58%3.34M10.07%2.53M-8.24%565.73K2.57%5.57M227.29%3.74M2,154.56%2.3M322.48%616.55K
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ----Unqualified opinion------Unqualified opinion------
Auditor ----Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg